Menopausal hormone therapy and risk factors of breast cancer development
The article reviews the literature data of the latest studies and expert conclusions on the relationship between menopausal hormone therapy and the risk of developing breast cancer.
Main Authors: | A E Protasova, S V Yureneva, E N Vandeeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2017-06-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28612/pdf |
Similar Items
-
Menopausal hormone therapy and uterine cancer: the acceptability of the tandem
by: O V Yakushevskaya, et al.
Published: (2018-12-01) -
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
by: Irene Lambrinoudaki
Published: (2021-01-01) -
Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
by: I. V. Vуsotskaya, et al.
Published: (2019-09-01) -
Vaginal bleeding during menopause hormone therapy. Is it always endometrial cancer? How to choose the appropriate tactics for examination and management of patients?
by: Anna E. Protasova, et al.
Published: (2020-11-01) -
Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study
by: M. Fornili, et al.
Published: (2021-04-01)